Trusted Biotechnology Experts

AI meets biotech — straight from Zug, Switzerland Get the latest AI news, learn must-know AI tools, and keep up with Biotech news in just 5 minutes a week. Join our readers growing their careers with the AIxBiotech newsletter. Founded by executives who have led global biotech and tech teams, AIxBiotech is on a mission to make AI practical for themodern biotech office. In just a few months, we’ve attracted a fast-growing audience of biotech professionals and innovation leaders — from early-stage founders to Fortune 500 executives. Our readers span Europe and North America, with a strong base in the U.S. and Switzerland. We’re building organically, one engaged reader at a time — with the ambition to reach 500K professionals within our first year.

With a PhD in molecular genetics and as a specialist in data science, Céline Chantry-Darmon has over twenty years of experience in biomedical research and complex data analysis. As Scientific Director at Tekkare, she works on developing trustworthy artificial intelligence for healthcare. She is also committed to promoting inclusive and responsible artificial intelligence, and to advancing women in science and technology.

Emanuele Andreano is an immunologist and biotech innovator redefining how vaccines are discovered for pandemic threats. As Head of Serology and Immunology at the Fondazione Biotecnopolo di Siena and a leader in the European Vaccine Hub, he works at the intersection of AI, immunology, and global health. He pioneered Reverse Vaccinology 3.0, a breakthrough approach that can identify entirely new vaccine targets in days instead of years. In a first-of-its-kind demonstration, his team showed that artificial intelligence can predict unknown viral antigens directly from human antibody sequences—effectively reversing the traditional vaccine discovery process. His work spans monoclonal antibody discovery and next-generation vaccines against emerging pathogens, including mpox and SARS-CoV-2, with direct implications for global pandemic preparedness and biosecurity. Andreano has received international recognition, including the Antonio Feltrinelli Prize from the Accademia Nazionale dei Lincei, awarded in the presence of the President of the Italian Republic Sergio Mattarella, the IUIS Rising Star in Immunology, and a European Research Council (ERC) grant. He also co-directs a vaccinology program at the Institut Pasteur in Paris. “We are entering an era where vaccines can be discovered at unprecedented speed—transforming our ability to fight pandemics and save countless lives.”

Dr. Robert Abraham is a regenerative medicine consultant and healthcare strategy advisor with more than a decade of experience operating multi-location healthcare practices. He earned his Bachelor of Science in Health Sciences and Biology from the University of Central Florida before pursuing advanced training in clinical operations and regenerative-focused program development. Based in Florida, Dr. Abraham has worked with healthcare organizations throughout the Orlando region and nationwide, advising clinics on structured implementation, operational systems design, revenue forecasting, and compliance-conscious growth within regenerative medicine and wound care services. In addition to his consulting work, he serves as Chief Executive Officer of Cross Biotech, a biologics distribution company supporting providers in aligning product access with disciplined operational frameworks. His work emphasizes infrastructure-driven expansion, leadership accountability, and sustainable healthcare systems.

Founder of IngredientMD, a supplement intelligence platform powdered by most clinical data available. What's important, we communicate in language humans will understand instead. It all starts from individual ingredients instead of product name, claims, and anything else. Product is what's inside instead of what perception is being made. In our analysis of 500+ supplement products, we found 42% had at least one key ingredient below clinically studied doses. I focus on bringing evidence-based analysis to consumer supplement decisions.

I build infrastructure for emerging technology transitions—and have been doing it for 20 years. Many know me for my work in digital health, where I spent two decades helping the industry understand how technology shapes behavior and decision-making. That work taught me something: every major platform shift creates new vulnerabilities and opportunities, and the companies that thrive are the ones who see them early. Today I'm focused on the agentic era—where AI systems operate autonomously and require fundamentally new approaches to security, commerce, and trust. WHAT I'VE SHIPPED Co-author of the #1 bestselling book ePatient 2015: 15 Surprising Trends Changing Healthcare (featured in Bloomberg, Forbes, and other publications). Co-founder of the FemAging Project, a global initiative driving women's health innovation. Creator of Femalytics, an AI-powered intelligence platform. Author of two FemAging Index studies, including one sponsored by AARP. Founder of Enspektos, LLC (est. 2005), which has evolved through Web 2.0, mobile, and ML eras—always at the intersection of emerging tech and real-world application. WHAT I'M BUILDING NOW AI Security Guard (aisecurityguard.io) is a multi-faceted platform for securing autonomous AI, combining protection APIs, product tooling, education, and original research on the agentic future.

Hello, I'm Gabrielle M., Founder and CEO of DERMA-CODE™ LLC. I co-authored Skincare Through Biology Made Simple with Dr. Mohan Muvvala, DO, MBA a peer-reviewed educational resource designed to close the gap between what consumers are told and what the science actually says. DERMA-CODE™ has been featured in Skin Inc. magazine, and I've been actively contributing pieces to Skin Inc. over the past several months. DERMA-CODE™ is a biotech skincare brand launched in November 2025 built around one principle: skincare should be grounded in biology, not marketing. The brand develops fully proprietary formulations with disclosed active percentages, no white labeling, and no paid placements. Our two hero products the PDRN + NAD+ Pulse Serum and Locked-In Moisturizer are currently undergoing an active REB-approved third-party clinical study using instrumented skin measurement and blinded dermatologist grading. I speak on ingredient science, formulation integrity, clinical evaluation, and the disconnect between industry claims and published research. When you quote me, you’re not getting a brand rep reading from a script. You’re getting a founder who has spent years inside the science working alongside a team of researchers to understand exactly how ingredients behave, how formulations are built, and where the industry falls short. Every answer I give is grounded in published research and real formulation experience. I don’t guess, I don’t generalize, and I don’t send talking points. If I’m the right source for your story, you’ll know it from my first response.

James Bean is a pioneering cannabis industry expert and Founding CEO of Seeds Here Now, the longest continuously operating seed bank in the United States with 15 years of proven leadership. Since 2010, Bean has built an industry-leading catalog featuring 3,500+ strains from 80+ world-class breeders, establishing Seeds Here Now as the premier destination for authentic cannabis genetics. With a Plant Science degree from Oaksterdam University and 15 years specializing in cannabis genetics, Bean brings unparalleled expertise in breeder verification, genetic authenticity, and cultivation science. His knowledge spans feminized, regular, and autoflower seed production, pheno-hunting, breeding practices, and strain lineage documentation. Bean's industry authority is demonstrated through extensive media presence on major cannabis podcasts including The Adam Dunn Show (as "James Bean Man on the Scene"), The Dude Grows Show, The Pot Cast, and Grow Bud Yourself Podcast. He has personally vended at hundreds of cannabis trade shows including High Times Cannabis Cups and Canna Con events, and serves as a cannabis competition judge. As a heavy cannabis consumer with decades of personal experience, Bean possesses exceptional first-hand knowledge of strain effects and quality assessment. His business has served thousands of satisfied customers with germination guarantees and transparent practices, earning recognition including the 2023 Leafly Seed Bank Hall of Fame honor and Forbes media coverage. Bean actively supports cannabis community causes, mentors emerging businesses, and contributes educational content through articles and podcast appearances. His direct relationships with renowned breeders like TH Seeds, Exotic Genetics, La Plata Labs, Snow High Seeds, and Dominion Seed Company underscore his trusted position as the "#1 U.S. Broker of High Quality Cannabis Genetics." Based in Tulsa, Oklahoma, Bean continues to shape cannabis breeding trends, preserve rare genetics, and advance industry professionalism while maintaining Seeds Here Now's position as America's most trusted source for authentic cannabis seeds.

Dr. James Utley is a pioneering scientist at the forefront of cellular therapy, AI, and data science. A Johns Hopkins-educated Immunohematology expert and Certified Advanced Biotherapies Professional (CABP), he also holds advanced certifications in data science and machine learning. While serving as Technical Director at a major healthcare organization, Dr. Utley oversaw more than 150,000 successful cellular transfusions and spearheaded advancements that significantly improved patient outcomes. This experience included leading initiatives for the Department of Defense, where he revolutionized cellular transfusion practices. His innovative approach is further exemplified by his FDA-approved work and numerous publications in leading scientific journals. Dr. Utley is also known for his bold, hands-on approach to research, embodying the spirit of a "biohacker" by pushing the boundaries of CRISPR and genetic engineering through self-experimentation. This unique blend of rigorous scientific training and unconventional methods has earned him the moniker "the pirate" within the biohacker community.

Dr. Akshaya Srikanth Bhagavathula is an Associate Professor of Epidemiology at North Dakota State University, internationally recognized for his pioneering work at the intersection of digital epidemiology, pharmacovigilance, and artificial intelligence. His research harnesses advanced statistical modeling and AI to track and predict health behaviors, medication safety, and disease patterns in real time—bridging traditional epidemiology with next-generation digital health analytics. Dr. Bhagavathula has published more than 250 peer-reviewed articles in leading journals, including Annals of Epidemiology, JAMA Network Open, and Lancet Digital Health. His work has been widely cited and featured in major media outlets such as The New York Times, where he discussed the real-world safety of GLP-1 receptor agonists like semaglutide (Ozempic, Wegovy, Mounjaro). Recognized among the Stanford–Elsevier Top 2% of Scientists (2019–2024) and elected as a Fellow of the American College of Epidemiology, Dr. Bhagavathula is known for translating complex data into actionable insights that shape public health policy and clinical practice. His ongoing projects include NIH- and NSF-aligned initiatives on AI-powered overdose forecasting, digital twins for public health, and real-world drug safety surveillance using explainable machine learning. With a decade of experience spanning more than two dozen countries and collaborations with organizations such as WHO, USAID, and UNICEF, Dr. Bhagavathula brings a global, data-driven, and human-centered approach to solving modern health crises.

Formerly a business owner in the fashion industry, I have redirected my career to catalyzing positive environmental change. As an Environmental Scientist and Project Manager I am hands on deploying ehnanced phytoremediation systems on contaminated and degraded sites throughout California. As an International Keynote Speaker, I am passionate about raising awareness and inspiring action on pressing environmental issues. Additionally, as a Native Plant Workshop Educator, I empower individuals to connect with their local ecosystems and promote biodiversity starting with their own backyard and communities. Join me in the environmental revolution, and together, we can make a lasting impact on our planet. Let's connect and collaborate for a greener, more sustainable future.

I'm a dedicated plant research scientist with a deep passion for harnessing the power of science and technology to enhance the field of agriculture. I am an expert in the development of Integrated Pest Management (IPM) strategies aimed at combating diseases in vegetable and fruit crops, both within the greenhouse and field environment, for improved productivity.I find great satisfaction in sharing my extensive agronomic knowledge and promoting agriculture products and services with different stakeholders.

Ryan Farmer is the founder of My Peptide Match, a consumer education site that helps people make sense of GLP-1 medications and the fast-changing peptide landscape. He focuses on simplifying complex topics—like real-world pricing, treatment pathways, sourcing differences, and what questions to ask—so readers can make more informed decisions with their clinician. Ryan tracks emerging trends across weight-loss peptides, compounding and telehealth access, and the economics that shape what consumers actually pay. He’s available to comment on GLP-1 and peptide cost comparisons, patient decision-making, and the broader market shifts driving demand. He also publishes practical reference tools, including a peptide calculator and dosage guide, to support clearer conversations between consumers and providers.

Joseph Fargnoli is a systems engineer turned AI architect and serial entrepreneur whose career spans defense, intelligence, healthcare, and the emerging space economy. He recently completed a Doctorate in Artificial Intelligence from GWU, building on graduate degrees in telecommunications, computer science, optics, electrical engineering, and national security affairs. His engineering background includes work at Northrop Grumman, Kodak, ITT, Exelis, and Harris, along with service at the National Reconnaissance Office. As Founder & CEO of RITRE Corporation, Founder of the New York Space Alliance, and Founder of SANABIT, he now channels that deep engineering background into ventures focused on social impact, healthcare innovation, and the next era of space entrepreneurship.

Vardan Ter-Antonyan is a pharmaceutical research and development executive with more than 20 years of experience advancing products from concept through commercialization. His expertise spans drug formulation, pharmaceutical development, manufacturing scale-up, quality systems, regulatory strategy, and commercialization across pharmaceuticals, medical devices, nutraceuticals, cannabinoids, and medical technologies. Throughout his career, Vardan has led multidisciplinary R&D teams, developed novel drug delivery systems, optimized manufacturing processes, and helped organizations bring innovative products to market while navigating complex regulatory requirements. His technical expertise includes lipid-based drug delivery systems, nanoemulsions, self-emulsifying drug delivery systems (SEDDS/SNEDDS), liposomes, controlled-release technologies, and formulation development for poorly water-soluble compounds. In addition to his scientific leadership, Vardan is passionate about bridging the gap between research and commercial success. He regularly advises companies on product development strategy, technology commercialization, operational excellence, and innovation management. His work combines deep scientific knowledge with practical business insight, enabling organizations to accelerate development timelines, improve product quality, and reduce technical risk. Vardan is also an author, speaker, and industry thought leader who enjoys sharing evidence-based perspectives on pharmaceutical innovation, drug delivery, biotechnology, diagnostics, manufacturing, and executive leadership. He welcomes opportunities to provide expert commentary for journalists covering advances in pharmaceutical science, healthcare innovation, biotechnology, regulatory affairs, and emerging medical technologies.

Independent neuroscience researcher and founder of PinealCode.com, where I publish evidence-based articles on pineal gland health, sleep science, and supplementation. My work covers fluoride accumulation in brain tissue, melatonin biochemistry, calcification mechanisms, and supplement efficacy — all referenced against primary literature from PubMed, NIH, Nature, and BMJ. Available to comment on brain health, sleep disorders, detoxification protocols, and the science behind popular wellness claims.

I am a practicing clinical pharmacist with over 20 years of experience and a graduate of St. John’s University School of Pharmacy in Queens, NY. With an undergraduate background in compounding and natural medicine, I have served in various capacities across the pharmaceutical industry before founding Fusion Medical Care in Scottsdale, AZ. My career is defined by my dedication to a balanced approach between natural and allopathic medicine, a passion that led me to develop a complete wellness center housing multiple integrative practitioners. Beyond my foundational education, I have advanced my specialized training through the Professional Compounding Centers of America and am a Certified Diplomate of the American Board of Anti-Aging Health Practitioners. I believe that my role as a pharmacist offers the perfect opportunity to fuse naturopathic and allopathic care, acting as a dedicated advocate for my patients' pharmacological and wellness needs. My mission is to empower patients to look and feel amazing by following my core philosophy: "Let your food be your medicine, your kitchen be your pharmacy, and your lifestyle be your doctor". My innovative approach to healthcare has earned me national recognition, including an honor in Marquis Who’s Who and a featured interview with VoyagePhoenix highlighting my journey and the mission behind Fusion Medical Care.

I entered the hemp space at the very beginning when there were almost no guardrails, no industry playbook, and very few operators who truly understood what it took to formulate something that actually worked. Hemp-derived flower and hemp wellness products were barely a category. What existed was largely untested, poorly sourced, and built around novelty rather than need. From day one, our approach was different purpose before profit, formulation before marketing, and a deep belief that every formulation should serve a real purpose. At JustKana, I oversee product development, quality control, and sourcing from the ground up. That means building relationships directly with small-batch organic hemp farms, evaluating raw material quality before it ever reaches a formulation stage, and ensuring every finished product meets both our internal standards and third-party lab verification. My work lives at the intersection of plant science and consumer wellness. I specialize in cannabinoid formulation for real therapeutic outcomes sleep support, chronic pain relief, anxiety management, and inflammation using full-spectrum hemp extracts that preserve the natural compound profile of the plant rather than isolating single ingredients. Over the years I've helped develop products that have made a measurable difference for thousands of people veterans managing PTSD, seniors dealing with chronic joint pain, and individuals looking to replace pharmaceutical sleep aids with something cleaner and plant-derived. That direct connection to consumer outcomes shapes every formulation decision I make. I understand the hemp supply chain from soil to finished product cultivation practices, extraction methods, cannabinoid and terpene profiles, and how sourcing decisions downstream directly impact what a customer experiences. In a space flooded with white-labeled, mass-produced products, that depth of knowledge is rare.

In my role, I meticulously oversee various clinical projects, ensuring each phase is executed with precision and in compliance with GCP standards. Core Competencies: Clinical Trials Monitoring Clinical Safety Protocols Streamlined Clinical Operations Regulatory Compliance Mastery Educational Background: MSc in Molecular Science and Nanotechnology, Louisiana Tech University MSc in Medical Genetics, MGM University of Health Sciences With a robust educational foundation and a keen eye for detail, I have successfully navigated through different therapeutic areas and regions, delivering high-quality results consistently. My journey in the realm of clinical research is driven by an insatiable curiosity and a deep-seated commitment to advancing science and practice. Let’s Connect! If you are passionate about transforming health care and improving patient lives, or if you wish to exchange insights and collaborate on projects, feel free to connect with me. Together, let’s contribute to a healthier, more understanding world for individuals navigating through challenges.

Shane Hellmrich holds a BSc in Health Promotion and has spent the past 11 years independently testing and reviewing online modafinil vendors — placing personal test orders, verifying product authenticity, and documenting shipping reliability across dozens of suppliers. His work at BuyModa.net tracks over 1,300 verified customer transactions and maintains a public testing methodology that has become a trusted reference point for consumers navigating the grey-market pharmaceutical space. Shane's research covers vendor reliability scoring, product authentication, shipping logistics across international jurisdictions, and the pharmacokinetic profiles of generic modafinil products. He is regularly consulted on topics including nootropics and cognitive enhancement, online pharmacy safety and regulation, pharmaceutical sourcing and supply chain transparency, consumer protection in unregulated markets, and the real-world usage patterns of prescription cognitive enhancers. Shane is available for expert commentary, background briefings, and on-the-record quotes for journalists covering health, productivity, pharmacology, biohacking, and consumer safety.